Literature DB >> 25677911

Successful management of chronic gastrointestinal hemorrhage using bevacizumab in the setting of hereditary hemorrhagic telangiectasia.

Mary E Sehl1, Theresa M Gruber1, Justin P McWilliams2, Victor J Marder1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25677911      PMCID： PMC5143277          DOI： 10.1002/ajh.23969

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  23 in total

1.  Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy.

Authors:  Tom T Karnezis; Terence M Davidson
Journal:  Laryngoscope       Date:  2011-12-06       Impact factor: 3.325

2.  Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab.

Authors:  Dimitri Flieger; Sabine Hainke; Wolfgang Fischbach
Journal:  Ann Hematol       Date:  2006-06-29       Impact factor: 3.673

3.  Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.

Authors:  Sophie Dupuis-Girod; Isabelle Ginon; Jean-Christophe Saurin; Denis Marion; Elsa Guillot; Evelyne Decullier; Adeline Roux; Marie-France Carette; Brigitte Gilbert-Dussardier; Pierre-Yves Hatron; Pascal Lacombe; Bernard Lorcerie; Sophie Rivière; Romain Corre; Sophie Giraud; Sabine Bailly; Gilles Paintaud; David Ternant; Pierre-Jean Valette; Henri Plauchu; Frédéric Faure
Journal:  JAMA       Date:  2012-03-07       Impact factor: 56.272

Review 4.  Hereditary hemorrhagic telangiectasia.

Authors:  A E Guttmacher; D A Marchuk; R I White
Journal:  N Engl J Med       Date:  1995-10-05       Impact factor: 91.245

5.  A retrospective analysis of low dose, intranasal injected bevacizumab (Avastin) in hereditary haemorrhagic telangiectasia.

Authors:  C Rohrmeier; H G Sachs; T S Kuehnel
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-31       Impact factor: 2.503

6.  Arteriovenous malformation in the adult mouse brain resembling the human disease.

Authors:  Espen J Walker; Hua Su; Fanxia Shen; Eun-Jung Choi; S Paul Oh; Grant Chen; Michael T Lawton; Helen Kim; Yongmei Chen; Wanqiu Chen; William L Young
Journal:  Ann Neurol       Date:  2011-03-17       Impact factor: 10.422

7.  Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia.

Authors:  Andrew Mitchell; Leon A Adams; Gerry MacQuillan; Jon Tibballs; Rohan vanden Driesen; Luc Delriviere
Journal:  Liver Transpl       Date:  2008-02       Impact factor: 5.799

8.  Bevacizumab attenuates VEGF-induced angiogenesis and vascular malformations in the adult mouse brain.

Authors:  Espen J Walker; Hua Su; Fanxia Shen; Vincent Degos; Gregory Amend; Kristine Jun; William L Young
Journal:  Stroke       Date:  2012-05-08       Impact factor: 7.914

9.  Tranexamic acid-bevacizumab synergy in HHT patients presenting pulmonary arteriovenous malformations.

Authors:  Alexis Lacout; Pierre Yves Marcy; Mostafa El Hajjam; Pascal Lacombe
Journal:  Med Hypotheses       Date:  2012-09-05       Impact factor: 1.538

10.  The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia.

Authors:  Jana Simonds; Frank Miller; Jess Mandel; Terence M Davidson
Journal:  Laryngoscope       Date:  2009-05       Impact factor: 3.325
View more
  3 in total

Review 1.  Iron Deficiency and the Small bowel​.

Authors:  David Westrich; Christine Hachem; Christine Boumitri
Journal:  Curr Gastroenterol Rep       Date:  2021-07-08

2.  Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia.

Authors:  George Ou; Cherry Galorport; Robert Enns
Journal:  World J Gastrointest Surg       Date:  2016-12-27

3.  Diagnostic yield of capsule endoscopy for small bowel arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis.

Authors:  Kevin Singh; Ayla Zubair; Andrew Prindle; Ahmed Jamal Nadeem; Gulam Khan
Journal:  Endosc Int Open       Date:  2019-01-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.